Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06018480 · ClinicalTrials.gov registry record · NA
The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation
A NA study, sponsored by Florida State University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT06018480 is a NA study that has completed, run by Florida State University. The registered enrollment target is 9 participants.
The verdict
NCT06018480, a NA study, has completed, sponsored by Florida State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
This research study seeks to determine the effects of an enzyme in the human body called NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of creatine monohydrate, a common sports performance supplement, on blood food and vessel function. Participants will undergo two study arms, one in which they consume a high carbohydrate meal pre- and post-creatine monohydrate supplementation and one in which they will consume a high carbohydrate meal pre- and post-placebo supplementation. Blood flow and endothelial function will be assessed before and for 4 hours following the consumption of a high-carbohydrate meal pre and post-supplementation (creatine monohydrate and placebo).
Interventions
- OTHER Creatine Monohydrate
- OTHER Maltodextrin (Placebo)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2023-08-29 |
| Est. Completion | 2024-01-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06018480
The ClinicalTrials.gov registry entry for NCT06018480 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Florida State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Creatine Monohydrate is the first listed.
NCT06018480 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06018480 about?
NCT06018480 is a clinical study titled "The Effect of NADPH Oxidase and Creatine Supplementation on Microvascular Blood Flow Regulation". This research study seeks to determine the effects of an enzyme in the human body called NADPH oxidase (NOX) on blood flow. In addition, the study will investigate the benefits of creatine monohydrate, a common sports performance supplement, on blood food and vessel function. Participants will under...
What is the current status of trial NCT06018480?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2023-08-29. Estimated completion is 2024-01-30.
What interventions are being tested in trial NCT06018480?
The interventions under investigation include: Creatine Monohydrate (OTHER), Maltodextrin (Placebo) (OTHER).
Who is sponsoring clinical trial NCT06018480?
This trial is sponsored by Florida State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.